DK394477A - - Google Patents

Info

Publication number
DK394477A
DK394477A DK394477A DK394477A DK394477A DK 394477 A DK394477 A DK 394477A DK 394477 A DK394477 A DK 394477A DK 394477 A DK394477 A DK 394477A DK 394477 A DK394477 A DK 394477A
Authority
DK
Denmark
Application number
DK394477A
Other languages
Danish (da)
Other versions
DK142413C (th
DK142413B (da
Inventor
S Ozaki
Y Ike
K Ishikawa
H Tamura
Original Assignee
Mitsui Toatsu Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals
Publication of DK394477A publication Critical patent/DK394477A/da
Publication of DK142413B publication Critical patent/DK142413B/da
Application granted granted Critical
Publication of DK142413C publication Critical patent/DK142413C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK394477AA 1976-09-06 1977-09-05 Analogifremgangsmåde til fremstilling af 1-acyloxymethyl-5-fluoruracilderivater. DK142413B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10571476A JPS5331676A (en) 1976-09-06 1976-09-06 Uracil derivatives and their preparation
JP10571476 1976-09-06

Publications (3)

Publication Number Publication Date
DK394477A true DK394477A (th) 1978-03-07
DK142413B DK142413B (da) 1980-10-27
DK142413C DK142413C (th) 1981-03-23

Family

ID=14414993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK394477AA DK142413B (da) 1976-09-06 1977-09-05 Analogifremgangsmåde til fremstilling af 1-acyloxymethyl-5-fluoruracilderivater.

Country Status (16)

Country Link
US (1) US4267326A (th)
JP (1) JPS5331676A (th)
AU (1) AU513153B2 (th)
CH (1) CH634567A5 (th)
DE (1) DE2739912A1 (th)
DK (1) DK142413B (th)
FI (1) FI62071C (th)
FR (1) FR2363563A1 (th)
GB (1) GB1543467A (th)
HU (1) HU177482B (th)
NL (1) NL7709808A (th)
PH (1) PH14000A (th)
PL (1) PL108914B1 (th)
SE (1) SE438856B (th)
SU (1) SU795468A3 (th)
ZA (1) ZA775361B (th)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5379879A (en) * 1976-12-23 1978-07-14 Mitsui Toatsu Chem Inc 1,3-substituted-5-fluorouracils and process for their preparation
JPS54122281A (en) * 1978-03-13 1979-09-21 Mitsui Toatsu Chem Inc 5-fluorouracil derivative and its preparation
JPS5668674A (en) * 1979-11-08 1981-06-09 Shionogi & Co Ltd 5-fluorouracil derivative
JPS5724369A (en) * 1980-07-19 1982-02-08 Tokyo Kinzoku Kogyo Kk Pyrimidine derivative and its preparation
JPS5738774A (en) * 1980-08-19 1982-03-03 Chugai Pharmaceut Co Ltd Uracil derivative and its preparation
WO1985001729A1 (en) * 1983-10-20 1985-04-25 Terumo Kabushiki Kaisha 5-fluorouracil derivatives and medicinal preparation containing same
DK197486A (da) * 1986-04-30 1987-10-31 Ferring Farma Lab 5-fluoruracilprodug
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
CA2766088C (en) 2009-06-25 2017-06-13 Alkermes, Inc. Heterocyclic compounds for the treatment of neurological and psychological disorders
ES2885698T3 (es) 2009-06-25 2021-12-15 Alkermes Pharma Ireland Ltd Profármacos de compuestos nh-ácidos
JP6654042B2 (ja) 2012-09-19 2020-02-26 アルカームス ファーマ アイルランド リミテッド 貯蔵安定性が改善された医薬組成物
CA2943213C (en) 2014-03-20 2022-07-05 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN109761915B (zh) * 2019-03-05 2021-12-21 沈阳药科大学 靶向mct1转运体的5-氟尿嘧啶成酯前药

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324951B2 (th) * 1973-11-28 1978-07-24
JPS603071B2 (ja) * 1975-02-17 1985-01-25 三井製薬工業株式会社 1−(α−アシロキシアルキル)−5−フルオロウラシル類の製造方法

Also Published As

Publication number Publication date
FR2363563A1 (fr) 1978-03-31
NL7709808A (nl) 1978-03-08
AU2857177A (en) 1979-03-15
FI62071C (fi) 1982-11-10
SE7709942L (sv) 1978-03-07
GB1543467A (en) 1979-04-04
FI772594A (fi) 1978-03-07
PL200685A1 (pl) 1978-10-09
SE438856B (sv) 1985-05-13
SU795468A3 (ru) 1981-01-07
DK142413C (th) 1981-03-23
CH634567A5 (de) 1983-02-15
ZA775361B (en) 1978-07-26
AU513153B2 (en) 1980-11-20
DK142413B (da) 1980-10-27
FI62071B (fi) 1982-07-30
JPS6114148B2 (th) 1986-04-17
JPS5331676A (en) 1978-03-25
DE2739912A1 (de) 1978-03-09
HU177482B (en) 1981-10-28
US4267326A (en) 1981-05-12
FR2363563B1 (th) 1980-06-20
PH14000A (en) 1980-11-28
PL108914B1 (en) 1980-05-31

Similar Documents

Publication Publication Date Title
DE2649885B1 (th)
FR2363563B1 (th)
DE2740727C3 (th)
FI762084A (th)
FR2363952B1 (th)
JPS5388449U (th)
JPS5750369B2 (th)
JPS5312944U (th)
JPS5323327U (th)
JPS5444294B2 (th)
JPS5546005B2 (th)
JPS5323435U (th)
DK106576A (th)
JPS52133358U (th)
JPS5310406U (th)
DK138344C (th)
JPS5622139Y2 (th)
JPS5639427B2 (th)
JPS5622202B2 (th)
JPS5370871U (th)
CS177800B1 (th)
JPS5367888U (th)
JPS5332017U (th)
DE2608298A1 (th)
CH606833A5 (th)

Legal Events

Date Code Title Description
PBP Patent lapsed